
MONARCH 3 (15417 | I3Y-MC-JPBM)
NCT02246621
JPBM
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer (MONARCH 3)
Status:
Closed to Accrual

III
Phase

1st
Line of Therapy

Advanced / Metastatic
Disease Stage

Biomarker(s)
ER+, HER2-
Investigational
Product
Abemaciclib (LY2835219
CDK4/6 Inhibitor (p.o.)
Treatment Arms
o Experimental: Abemaciclib + NSAI
o Placebo Comparator: Placebo + NSAI